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CARMIL2 is a novel molecular connection
between vimentin and actin essential for cell
migration and invadopodia formation
M. Hunter Lanier, Taekyung Kim, and John A. Cooper
Department of Cell Biology and Physiology, Washington University in St. Louis, St. Louis, MO 63110

ABSTRACT Cancer cell migration requires the regulation of actin networks at protrusions
associated with invadopodia and other leading edges. Carcinomas become invasive after
undergoing an epithelial–mesenchymal transition characterized by the appearance of vimentin filaments. While vimentin expression correlates with cell migration, the molecular connections between vimentin- and actin-based membrane protrusions are not understood. We report here that CARMIL2 (capping protein, Arp2/3, myosin-I linker 2) provides such a molecular
link. CARMIL2 localizes to vimentin, regulates actin capping protein (CP), and binds to membranes. CARMIL2 is necessary for invadopodia formation, as well as cell polarity, lamellipodial assembly, membrane ruffling, macropinocytosis, and collective cell migration. Using
point mutants and chimeras with defined biochemical and cellular properties, we discovered
that localization to vimentin and CP binding are both essential for the function of CARMIL2
in cells. On the basis of these results, we propose a model in which dynamic vimentin filaments target CARMIL2 to critical membrane-associated locations, where CARMIL2 regulates
CP, and thus actin assembly, to create cell protrusions.
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INTRODUCTION
Invasion of body tissues by metastatic tumor cells is the main cause
of death in patients with cancer (Weigelt et al., 2005). Cell migration
and invasion require assembly of actin-based structures, such as invadopodia. Within invadopodia and at the leading edge of migrating cells in general, actin filaments polymerize at their barbed ends,
which are oriented toward the plasma membrane. The addition of
actin subunits onto barbed ends provides the force that generates
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protrusion of the plasma membrane. Regulation of the number of
free barbed ends is crucial for controlling actin networks during cell
migration and invasion (Pollard and Cooper, 2009).
Invadopodia and protrusions at the leading edges of migrating
cells are based on assemblies of branching networks of short actin
filaments interspersed with bundles of longer unbranched filaments (Cooper and Sept, 2008; Nurnberg et al., 2011). A key regulator of actin filament barbed ends is capping protein (CP). For
branched networks that are induced to form by the Arp2/3 complex, CP contributes to network assembly and architecture by capping older filaments, which restricts filament length and confines
polymerization to new filaments near the membrane (Cooper and
Sept, 2008; Pollard and Cooper, 2009; Pollard and Borisy, 2003;
Nurnberg et al., 2011). Loss of CP in cells leads to loss of Arp2/3based lamella and lamellipodia, increased numbers of filopodia,
and decreased cell migration (Mejillano et al., 2004). Therefore
insight into the regulation of CP is critical for understanding actinbased motility.
CARMIL (CP, Arp2/3, myosin-I linker) family proteins are large
(∼1400 aa) multidomain polypeptides that directly bind and regulate CP (Edwards et al., 2014). CARMILs contain a CP-binding region (CBR) that interacts with CP via two motifs in tandem: the
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FIGURE 1: CARMIL2 localizes to dynamic vimentin filaments at the
leading edge of migrating cells. (A) Domain map of CARMIL2.
(B) Localization of expressed CARMIL2-GFP, compared with vimentin
and F-actin, in the top panels. Arrow, example of colocalization of
CARMIL2-GFP with vimentin; arrowhead: example of CARMIL2-GFP
localization in leading-edge ruffles. Bottom panels show a negative
control with expressed GFP. (C) Dynamics of expressed vimentin4578 | M. H. Lanier et al.

CP-interaction (CPI) motif and the CARMIL-specific interaction
(CSI) motif (Hernandez-Valladares et al., 2010). CARMIL proteins
have similar domain architectures (Figure 1A), consisting of an Nterminal noncanonical pleckstrin homology (PH) domain, a leucinerich repeat (LRR) domain, a helical homodimerization domain (HD),
and an extended intrinsically disordered region that contains the
CBR and a proline-rich domain (PRD), which interacts with SH3 domains of class-I myosins (Zwolak et al., 2013; Edwards et al., 2014).
Vertebrates have three genes encoding highly conserved CARMIL isoforms that have distinct cellular functions (Liang et al.,
2009; Edwards et al., 2014). CARMIL1 regulates CP at the leading
edges of migrating cells, playing critical roles in lamellipodia formation, ruffling, and macropinocytosis (Edwards et al., 2013). For
CARMIL2 and CARMIL3, much less is known. CARMIL2 was identified as a transcript down-regulated in the affected skin of psoriasis
patients (Matsuzaka et al., 2004). Widely expressed in human tissues (Matsuzaka et al., 2004), CARMIL2 has been implicated in
costimulation pathways leading to T-cell activation (Liang et al.,
2013). Cultured HT1080 fibrosarcoma cells lacking CARMIL2 show
impaired migration in wound-healing assays, diminished lamellipodial ruffling, decreased macropinocytosis, and a striking cell
polarity phenotype characterized by multiple leading edges that
pull the cell in different directions (Liang et al., 2009). In addition,
CARMIL2 was found to localize to vimentin intermediate filaments
(Liang et al., 2009), the significance of which has not been
addressed.
The connection of CARMIL2 to vimentin is intriguing, because
vimentin appears to play a critical role in actin-based cell migration.
First, vimentin expression is a hallmark of the epithelial–mesenchymal transition in metastatic carcinomas, correlating with the migration and invasion potential of cancer cells (Gilles et al., 1999; Eckes
et al., 2000; Savagner, 2010; Rogel et al., 2011; Satelli and Li, 2011;
Menko et al., 2014). Second, vimentin filaments have been functionally linked to processes that require coordination of the actin network during cell migration and invasion (Schoumacher et al., 2010;
Helfand et al., 2011; Sakamoto et al., 2013; Sutoh Yoneyama et al.,
2014; Havel et al., 2015). However, the mechanisms by which vimentin influences actin-based cell motility remain poorly understood.
We reasoned that CARMIL2 was a strong candidate to connect the
vimentin and actin filament systems, because CARMIL2 localizes to
vimentin in cells and can regulate actin polymerization through its
interaction with CP.
In this study, we investigated the physiological relevance of
localization to vimentin and binding to CP with respect to the role
of CARMIL2 in cell migration and invadopodia formation. We observed CARMIL2 localization to dynamic vimentin filaments at the
leading edges of cells, identified the vimentin-localizing region of
CARMIL2, and characterized the biochemical interaction between CARMIL2 and CP. Most important, using expression of
specific mutants and chimeras, we found that both localization to
vimentin and the ability to bind CP are completely necessary for
function, including invadopodia formation as assayed by matrix
degradation.

tdTomato in frames from live-cell movies (Supplemental Movies S1
and S2). Arrowheads, examples of dynamic vimentin filaments at the
leading edge. (D) Colocalization of CARMIL2-GFP with dynamic
vimentin-tdTomato filaments at the leading edge (arrowheads).
Frames from a live-cell movie (Supplemental Movie S3). Scale bars:
10 μm. (E) Kymograph of vimentin filament boxed in yellow from
panel D.
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RESULTS
CARMIL2 localizes to dynamic vimentin filaments at leading
edges
We examined the mechanism and significance of the colocalization
of CARMIL2 with vimentin and hypothesized that CARMIL2 links vimentin filaments with actin assembly at the membrane. We then
asked whether CARMIL2 localizes to dynamic vimentin filaments at
the edges of cells, where actin assembly is dynamic. First, using expressed CARMIL2–green fluorescent protein (GFP), we confirmed
colocalization of CARMIL2 with the bulk of vimentin filaments in the
central cytoplasm, accompanied by localization of CARMIL2 in leading-edge ruffles (Figure 1B). Next we imaged individual vimentin
filaments at the edge of migrating HT1080 cells, using expressed
vimentin-tdTomato. We found that vimentin formed highly dynamic,
thin, filamentous structures in close proximity to the plasma membrane (Figure 1C and Supplemental Movies S1 and S2), consistent
with findings in other motile cells (Helfand et al., 2011; Sakamoto
et al., 2013; Havel et al., 2015). We observed motile filaments of vimentin at the leading edge, extending toward and retracting away
from the membrane.
To determine whether CARMIL2 localized to these dynamic
vimentin filaments, we coexpressed CARMIL2-GFP with vimentintdTomato. In live-cell movies of single migrating cells, CARMIL2-GFP
colocalized along the length of dynamic vimentin filaments at the
leading edge (Figure 1D and Supplemental Movie S3). Heat-map
pseudocoloring was used to show enrichment of CARMIL2-GFP on
vimentin filaments. To investigate the timing of vimentin-filament retraction and extension with respect to CARMIL2 colocalization along
filaments, we created kymographs, drawing lines along vimentin filaments (Figure 1E). Vimentin and CARMIL2 dynamics were coincident
in time, consistent with CARMIL2 bound to vimentin filaments that
extend and retract by trafficking along microtubules via microtubule
motors, a model previously described by others (Gyoeva and Gelfand, 1991; Prahlad et al., 1998; Helfand et al., 2002).

CARMIL2-LRR is necessary and sufficient for localization
to vimentin
To create probes for testing the functional significance of localization to vimentin by CARMIL2, we first identified regions of CARMIL2
necessary and sufficient for localization to vimentin. We used GFP
fusions of CARMIL2 truncations and chimeras of CARMIL2 with
CARMIL1, with truncation and fusion sites determined from secondary structure predictors (PSIPRED) and the CARMIL1 crystal structure
(Zwolak et al., 2013; Figure 2A). First, we observed that the N-terminal half of CARMIL2 (N-Term) localized with vimentin, but the Cterminal half (C-Term) did not. Instead, the C-Term of CARMIL2 localized to leading-edge membranes, including ruffles (Figure 2B).
Dividing the N-Term further, we found that localization to vimentin
was seen with the LRR domain and not with the PH domain
(Figure 2B). Smaller fragments were not tested, because they were
not expected to be stable, based on previous biochemical studies
(Zwolak et al., 2013).
Next we constructed chimeras between CARMIL1 and CARMIL2,
interchanging the PH domains, the LRR domains, and the C-Terms
of each protein. Splice sites were determined using sequence alignments and the CARMIL1 crystal structure to avoid disrupting secondary structures. Chimeras were created and cloned into GFP-fusion expression vectors using Gibson assembly (Gibson, 2011). First,
we tested chimeras composed of domains from the N-Term of the
protein. The PH domain of CARMIL1 fused to the LRR domain of
CARMIL2 (PH1/LRR2) localized to vimentin, while the converse construct, PH2/LRR1, did not. Next we tested chimeras consisting of
Volume 26 December 15, 2015

full-length protein. A chimera composed of the PH domain of CARMIL1 (PH1) with the LRR domain of CARMIL2 (LRR2) and the C-Term
of CARMIL1 (C-Term1), PH1/LRR2/C-Term1, localized to vimentin
filaments, whereas the converse chimera, PH2/LRR1/C-Term2, localized to the leading-edge membrane, including ruffles (Figure 2B).
We conclude that information in the LRR domain of CARMIL2 is
necessary and sufficient for localization with vimentin in the context
of full-length CARMIL or the N-Term of CARMIL.
We further divided the LRR domain, which consists of 16 LRRs.
The LRR domain has a highly conserved region in the eighth repeat,
on the ascending loop between the β-strand and α-helix (Zwolak
et al., 2013). Using this location as a splice site, we observed that
chimeras with the first eight LRRs of CARMIL2 (LRRN2) and the second eight LRRs of CARMIL1 (LRRC1), expressed in the context of the
N-Term of CARMIL, localized to vimentin; however, the degree of
localization to vimentin for these split constructs was not as strong
as for those chimeras with all 16 LRRs from CARMIL2. Thus the first
eight LRRs are more important for localization to vimentin than the
second eight LRRs, but the second eight repeats do make a noticeable contribution.
To quantify colocalization with vimentin, we calculated the Manders overlap coefficients for the CARMIL2 truncations and chimeras
(Figure 2C). In support of the qualitative observations, the values
revealed that truncations and chimeras containing the LRR domain
of CARMIL2 overlapped significantly more with vimentin than constructs that did not. Chimeras with the first eight LRRs displayed intermediate levels of overlap with vimentin filaments, also consistent
with the qualitative observations.
To extend the analysis, we collected dual-label movies of living
migrating cells and examined localization patterns for full-length
CARMIL-GFP chimeras with vimentin-tdTomato (Figure 2D and Supplemental Movies S4–S9), using heat-map pseudocoloring of CARMIL2-GFP. Wild-type CARMIL2-GFP was observed on dynamic vimentin filaments, as noted above. Localization to vimentin was
found with the PH1/LRR2/C-Term1 chimera but not the PH2/LRR1/
C-Term2 chimera, which localized to leading-edge membranes and
ruffles. The N-Term of CARMIL2 localized with vimentin, and the CTerm localized to leading-edge membrane ruffles. Thus the movie
analysis of living cells confirmed the previous single-image results,
in every respect.

CARMIL2 mutant unable to bind CP
Human CARMIL2, like all vertebrate CARMILs, contains a domain
called the CP-binding region (CBR), which includes two tandem CPbinding motifs: CPI and CSI (Figure 1A; Hernandez-Valladares et al.,
2010; Edwards et al., 2014). For CARMIL1, biochemical studies
showed that the CBR region is sufficient to bind CP and decrease
the actin-capping activity of CP (Yang et al., 2005; Fujiwara et al.,
2010; Hernandez-Valladares et al., 2010; Zwolak et al., 2010; Kim
et al., 2012; Edwards et al., 2013). This ability had not been tested
for any CARMIL2 isoform, so we performed the relevant assays here
for human CARMIL2, using the putative CBR, consisting of Pro-961
to Arg-1072.
First, we tested the ability of CARMIL2-CBR to inhibit actin capping by CP in a pyrene-actin–seeded polymerization assay. In this
assay, CP inhibits polymerization of actin by binding to the barbed
ends of growing filaments. Inhibition by CP was relieved with increasing concentrations of CARMIL2-CBR (Figure 3A). Kinetic modeling with a simple 1:1 mechanism for CBR binding to CP (reaction 3,
Materials and Methods section) fitted the data well, yielding an
apparent Kd of 2.9 ± 0.4 nM. Second, we tested the ability of
CARMIL2-CBR to uncap actin filaments that are capped by CP,
CARMIL2 links vimentin and actin
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FIGURE 2: LRR domain of CARMIL2 is necessary and sufficient for localization to vimentin. (A) Domain map of CARMIL2
indicating CARMIL2 truncations and CARMIL1/CARMIL2 chimeras, along with summary of localization to vimentin
results. (B) Localization of CARMIL-GFP fusion proteins compared with vimentin-tdTomato. (C) Manders overlap
coefficients for expressed CARMIL2-GFP fusion proteins and vimentin-tdTomato. Number of data points as follows: GFP,
2; CARMIL2, 4; N-Term, 5; C-Term, 4; PH, 4; LRR, 3; PH1/LRR2/C-Term1, 5; PH2/LRR1/C-Term2, 4; PH1/LRR2, 5; PH2/
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significance as follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001. (D) Initial frame of movies (Supplemental Movies S4–S9)
comparing localization of expressed CARMIL-GFP fusion proteins with vimentin-tdTomato. Scale bars: 10 μm.

another known property of CARMIL1 (Yang et al., 2005; HernandezValladares et al., 2010; Kim et al., 2012; Edwards et al., 2013). We
modified the pyrene-actin–seeded polymerization assay by adding
CARMIL2-CBR after, not before, the actin barbed ends were capped
by CP. The rate of actin polymerization increased rapidly, consistent
with uncapping (Figure 3B). We conclude that CARMIL2 binds and
inhibits CP, with a level of activity similar to that observed previously
for CARMIL1 (Kim et al., 2012).
Next we created a CARMIL2 mutant defective in binding CP, by
changing two amino acid residues. CARMIL2 contains a CPI motif,
defined as LxHxTxxRPK(x)6P (Bruck et al., 2006), and cocrystal struc4580 | M. H. Lanier et al.

tures of CARMIL1-CBR with CP show several close contacts between
the CPI motif and CP (Hernandez-Valladares et al., 2010). In previous work with CARMIL1, we found that changing two basic residues,
K987 and R989, to alanine led to a nearly complete loss of binding
(Edwards et al., 2013). We mutated the analogous residues of CARMIL2-CBR, R985 and R987, to alanine. Repeating the pyrene-actin–
seeded polymerization assays, we found that the mutant had little to
no ability to interact with CP, either in the assay for inhibition of
capping (Figure 3C) or the assay for uncapping (Figure 3D).
These assays were performed with the CBR fragment, using purified proteins in vitro. In a complementary approach, we tested the
Molecular Biology of the Cell
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ability of full-length CARMIL2, wild-type and mutant, to interact with
CP in HT1080 cells by immunoprecipitation. We found that CP
coprecipitated with FLAG-tagged wild-type CARMIL2. In contrast,
CP did not coprecipitate with the RR985/987AA mutant form of
FLAG-CARMIL2 (Figure 3E). On the basis of these results, we conclude that the interaction of CARMIL2 with CP was essentially lost in
the RR985/987AA mutant.

The physiological significance of CARMIL2 interaction with
vimentin and CP
We used the CARMIL2/CARMIL1 chimeras and the CARMIL2
RR985/987AA mutant to test the physiological significance of localization to vimentin and CP binding for the function of CARMIL2. We
asked whether expression of the chimeras or the mutant was able to
rescue traits that result from loss of CARMIL2 (Liang et al., 2009). To
deplete endogenous CARMIL2, we used a lentiviral system to deliver short hairpin RNA (shRNA) targeting CARMIL2. A second lentivirus was used to introduce shRNA-resistant versions of GFP fusions
of the chimeras and mutants. Immunoblots confirmed that endogenous CARMIL2 was depleted and that the expression levels of the
rescue constructs were appropriate (Figure 4A).
We first examined the cell polarity, lamellipodial assembly, ruffling, and macropinocytosis defects resulting from loss of CARMIL2
(Liang et al., 2009). Phase-contrast movies of individual, randomly
migrating CARMIL2-depleted and expression-rescue cells were collected (Figure 4B and Supplemental Movies S10–S16). Uninfected
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cells and cells infected with a scramble-sequence shRNA served as
negative controls. In the movies, CARMIL2-depleted cells exhibited
a polarity defect, with multiple protrusions pulling the cell in many
directions (Figure 4B), as previously described (Liang et al., 2009).
The leading edges of CARMIL2-depleted cells were smooth and
flat, lacking the prominent lamellipodia and membrane ruffles seen
in the controls. In addition, the depleted cells formed few macropinosomes, consistent with the loss of ruffles, which mediate macropinosome formation (Kerr and Teasdale, 2009).
We quantitated the cell polarity defect by calculating the circularity of the cell (Figure 4C), defined as the area of the cell divided
by the area of a circle with the same perimeter as the cell (see
Materials and Methods). We quantitated macropinocytosis by
counting the number of macropinosomes per cell (Figure 4D). Loss
of CARMIL2 led to statistically significant moderate decreases in the
value of circularity and large decreases in the number of macropinosomes (Figure 4, C and D).
To test for rescue by expression, we first confirmed that all of the
traits of the CARMIL2-depletion phenotype could be rescued by
expression of shRNA-resistant wild-type CARMIL2, demonstrating
that the effects of the shRNA were specific for CARMIL2, without
off-target effects (Figure 4, B–D).
We found that expression of the CARMIL chimera PH2/LRR1/CTerm2, which does not localize to vimentin, did not rescue any of
the traits of the loss-of-function phenotype (Figure 4, B–D). However, expression of the converse chimera, PH1/LRR2/C-Term1,
which does localize to vimentin, was able to provide full rescue
(Figure 4, B–D). Thus localization to vimentin is necessary for the
function of CARMIL2 in cells. The results with the converse chimera
show that providing CARMIL1 with the ability to localize to vimentin
(by changing the LRR domain) is sufficient to allow CARMIL1 to substitute for CARMIL2. Thus the LRR of CARMIL2 has a specific and
essential function, while the functions of the other domains are similar for CARMIL1 and CARMIL2.
Expression of the CP-binding mutant did not rescue any of the
traits caused by loss of CARMIL2 (Figure 4, B–D). Thus the ability of
CARMIL2 to bind CP is also completely necessary for its function.
To quantify single-cell migration, we calculated the persistence,
distance traveled, and mean-square displacement of randomly migrating individual cells. We found no differences between untreated, CARMIL2-depleted, or any of the rescue conditions
(Figure 4, E–G). From these results, we concluded that loss of
CARMIL2 has no effect on single-cell migration in the absence of
a directional cue.
Next, to investigate the hierarchy of the molecular interactions,
we examined the vimentin and lamellipodial actin networks in the
depletion and expression-rescue cells by staining cells with anti-vimentin, anti-CP, and fluorescent phalloidin. The vimentin filament
networks were similar in all cases (Figure 4H). In contrast, disruptions
of the lamellipodial actin network were observed when CARMIL2
function was not present. Anti-CP staining, which in control cells was
prominent at the leading edge and in puncta surrounding macropinosomes, was greatly diminished at those locations in cells lacking
CARMIL2 (Figure 4H). The CP-staining pattern was rescued by expression of shRNA-resistant wild-type CARMIL2 and the PH1/LRR2/
C-Term1 chimera, whereas the staining pattern of the PH2/LRR1/CTerm2 chimera and the RR985/987AA CP-binding mutant resembled
CARMIL2-depleted cells. Examination of the F-actin network with
fluorescent phalloidin yielded similar results (Figure 4H). CARMIL2depleted cells showed decreased phalloidin staining, and this was
rescued by expression of the PH1/LRR2/C-Term1 chimera but not
the PH2/LRR1/C-Term2 chimera or the RR985/987AA CP-binding
CARMIL2 links vimentin and actin
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Collective cell migration depends on localization to vimentin
but not CP-binding ability
We investigated the importance of the individual biochemical and
cellular functions of CARMIL2 for the process of cell migration in
wound healing. Cell migration defects in wound-healing assays
have been described for cells lacking CARMIL2 (Liang et al.,
2009). Here we first confirmed that CARMIL2-depleted cells migrate slowly, compared with control cells, when they fill a scratch
wound in a tissue-culture monolayer (Figure 5A). The rate of
movement of the edge of the monolayer was decreased by almost half (Figure 5B).
We found that expression of wild-type CARMIL2 and the PH1/
LRR2/C-Term1 chimera rescued the migration defect completely
(Figure 5, A and B); however, expression of the PH2/LRR1/C-Term2
chimera had no effect. Thus the ability of CARMIL2 to interact with
vimentin is necessary for the function of CARMIL2 in cell migration
in wound healing.
In a surprising contrast, expression of the CP-binding mutant
RR985/987AA rescued the cell migration defect completely (Figure
5, A and B), which was not the case for all the other loss-of-function
traits discussed above, including cell polarity, lamellipodial assembly, ruffling, and macropinocytosis. Thus the absence of lamellipodia and ruffling in the CP-binding mutant cells had no effect on the
rate of cell migration, indicating that these prominent dynamic features of the leading edge are not important for cell migration in the
context of wound healing. This conclusion is consistent with other
studies of cells with impaired lamellipodial assembly created by
other perturbations (Gupton et al., 2005; Suraneni et al., 2012; Wu
et al., 2012; Edwards et al., 2013).
Together these results lead us to two conclusions. First, the localization to vimentin function of CARMIL2, but not the ability to bind
CP, is necessary for collective cell migration. Second, lamellipodia
and ruffles are dispensable for cell migration in the wound-healing
setting.

Invadopodia formation and matrix degradation
Vimentin filaments have been proposed to play a role in the formation of invadopodia (Schoumacher et al., 2010; Sutoh Yoneyama
et al., 2014). Invadopodia are filled with dynamic actin filament networks nucleated by the Arp2/3 complex (Buccione et al., 2004;
Lorenz et al., 2004; Yamaguchi et al., 2005; Weaver, 2006). We hypothesized that CARMIL2 might serve as a molecular link connecting vimentin to actin assembly in invadopodia. To assay invadopodia formation, we performed matrix-degradation assays by imaging
the loss of fluorescent matrix under HT1080 cells. In control cells,
sites of matrix degradation were found in association with bright
puncta of F-actin, which are the defining hallmarks of invadopodia
(Figure 6A; Chen, 1989). In contrast, sites of matrix degradation
were absent in CARMIL2-depleted cells, based on qualitative observations of images and a quantitative method of image analysis that
involved converting the fluorescent-matrix image to a binary format
(Figure 6B; see Materials and Methods). The matrix-degradation
phenotype was rescued by expression of wild-type CARMIL2 and
the PH1/LRR2/C-Term1 chimera, but not the PH2/LRR1/C-Term2
chimera or the RR985/987AA CP-binding mutant. On the basis of
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mutant. On the basis of these results, we conclude that the abilities
of CARMIL2 both to localize to vimentin and to bind CP are necessary for lamellipodial actin assembly, membrane ruffling, macro
pinocytosis, and cell polarity.

FIGURE 6: Invadopodia formation and degradation of underlying
matrix depends on abilities of CARMIL2 to localize to vimentin and to
bind CP. (A) Uninfected cells and CARMIL2-depleted cells plated on
fluorescent gelatin. Invadopodia (arrowheads) are identified with
fluorescent phalloidin staining. Sites of matrix degradation are
identified as dark areas in the fluorescent gelatin image. For
quantification, the fluorescent gelatin image was converted with a
threshold set at 3 SDs below mean pixel intensity. Scale bar: 10 μm.
(B) Quantification of matrix degradation. Mean percent of cell area with
matrix degradation in threshold images for CARMIL2-depletion and
expression-rescue cells. Error bars are SEM. n = 20 cells. *, p < 0.0001.
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these results, we conclude that the ability of cells to degrade matrix
depends on CARMIL2’s ability to interact with vimentin and bind CP.

DISCUSSION
In this study, we report the discovery of a novel molecular connection between vimentin intermediate filaments and lamellipodial actin dynamics. First, we found that CARMIL2 localizes to dynamic vimentin filaments at the leading edges of migrating cells, mediated
by its LRR domain. We showed that CARMIL2 binds and inhibits CP,
similar to other CARMILs. Most important, we created mutants and
chimeras with specific functional properties, which demonstrate that
both localization to vimentin and the CP-binding ability of CARMIL2
are necessary for the function of CARMIL2 in invadopodia formation
and cell migration, hallmarks of malignant cancers.
CARMIL family proteins have similar domain architectures, with a
high degree of sequence similarity throughout (Liang et al., 2009;
Zwolak et al., 2013). However, the three vertebrate isoforms possess
highly conserved differences that distinguish one from another (Edwards et al., 2014), suggesting that they have different functions.
Our previous work revealed that CARMIL1 and CARMIL2 have different localizations and functions in cultured human cells. Most important, expression of one was not able to rescue phenotypes resulting from loss of the other (Liang et al., 2009).
CARMIL2 is known to colocalize with vimentin filaments (Liang
et al., 2009). However, the physiological significance and mechanism of the interaction was not known. In addition, the extent of
colocalization was not examined, especially whether CARMIL2 colocalized with dynamic vimentin filaments at the cell edge. Vimentin
filaments at the leading edge are particularly interesting because of
evidence linking vimentin to processes of membrane-associated actin assembly, including the formation of cell protrusions, notably invadopodia, which are features of cancer cells invading tissue (Schoumacher et al., 2010; Helfand et al., 2011; Sakamoto et al., 2013;
Sutoh Yoneyama et al., 2014; Havel et al., 2015).
To investigate the mechanism and significance of the vimentin–
CARMIL2 interaction, we first identified the LRR domain of CARMIL2 as necessary and sufficient for localization to vimentin. LRR
domains of other proteins, including NOD2 and NLRP3, also interact with vimentin (Stevens et al., 2013; dos Santos et al., 2015), but
we found no obvious sequence or structural similarities between
those LRR domains and the LRR domain of CARMIL2. To test the
physiological significance of CARMIL2’s localization to vimentin, we
created chimeras with specific loss or gain of vimentin interaction by
exchanging LRR domains between CARMIL1 and CARMIL2. Our results show that the ability to interact with vimentin is completely
necessary for CARMIL2 to function and that addition of this ability to
CARMIL1 is sufficient to allow CARMIL1 to function in place of
CARMIL2.
Loss of CARMIL2 causes a number of phenotypes (Liang et al.,
2009). We found that PH2/LRR1/C-Term2, the chimera that does not
localize to vimentin, was unable to rescue defects in lamellipodia,
ruffling and macropinocytosis; these membrane-associated phenomena depend on one another and on actin assembly (Chhabra
and Higgs, 2007; Kerr and Teasdale, 2009). This chimera was also
unable to rescue the distinctive cell polarity defect displayed by
CARMIL2-depleted cells, which resembles the polarity defects of
cells lacking myosin-IIB, Cdc42, or PAK1 (Nobes and Hall, 1999;
Sells et al., 1999; Lo et al., 2004; Cau and Hall, 2005; Liang et al.,
2009; Parrini et al., 2009).
We also found that localization to vimentin is important for CARMIL2’s role in collective cell migration, based on wound-healing assays, and for formation of invadopodia, based on matrix-degradation
4584 | M. H. Lanier et al.

assays. Vimentin expression is a hallmark of the epithelial–mesenchymal transition of carcinomas, correlating with the potential for cancer
cells to migrate and invade (Gilles et al., 1999; Eckes et al., 2000;
Savagner, 2010; Rogel et al., 2011; Satelli and Li, 2011; Menko et al.,
2014), so CARMIL2 may be a critical link that connects vimentin to
invasion and migration of cancer cells.
In contrast to collective cell migration, random migration of individual cells is not affected by loss of CARMIL2. Collective cell
migration depends on guidance of leader cells and cooperation of
follower cells. This is mediated by localization of key proteins, such
as Rac1, to the leading edge and transduction of migrational cues
through cell–cell junctions, respectively (Friedl, 2004; Dumortier
et al., 2012; Collins and Nelson, 2015; Haeger et al., 2015;
Yamaguchi et al., 2015). CARMIL2 depletion does not disrupt the
ability of cells to maintain contact during wound healing, and the
overall levels of Rac1 activation are not decreased in CARMIL2depleted cells (Liang et al., 2009). However, the localization of activated Rac1 in CARMIL2-depleted cells may be impaired during
wound healing. If so, then localization of active Rac1 would depend on the ability of CARMIL2 to localize to vimentin but not
bind CP. Elucidating the differences in the role of CARMIL2 between random and directed migration requires further study.
One striking result was that replacement of the LRR domain of
CARMIL1 with the vimentin-localizing LRR domain of CARMIL2 was
sufficient to rescue CARMIL2 phenotypes. Thus the other domains
of CARMIL1, including the noncanonical PH domain, the CBR, the
basic and hydrophobic membrane-binding domain (Brzeska et al.,
2010), and the PRD, have sufficient functional overlap to replace the
corresponding domains of CARMIL2. Only the LRR domain has a
specific function unique to CARMIL2. Of note, the chimera of
CARMIL2 with the CARMIL1 LRR (PH2/LRR1/C-Term2) localizes to
the leading edge but is not able to rescue the lamellipodial defects
of CARMIL2-depleted cells. This observation suggests that the key
function of CARMIL2 is to provide a functional connection between
vimentin filaments and membrane-associated actin during cell migration and invasion.
We investigated the physiological significance of the ability of
CARMIL2 to bind and inhibit CP, which has been established for
CARMIL1 (Edwards et al., 2013). We found that the apparent affinity for CARMIL2 binding to CP was similar to that of CARMIL1
(Hernandez-Valladares et al., 2010; Kim et al., 2012), consistent
with the sequence similarities and the cocrystal structures. In addition, we found a mutant form of CARMIL2 with a nearly complete
loss of the ability to bind CP was unable to rescue the loss of lamellipodial ruffling, macropinocytosis, cell polarity, and invadopodia-mediated matrix degradation. Thus the ability to bind CP is
necessary for the function of CARMIL2 in cells, as is the case for
CARMIL1 (Edwards et al., 2013). This result supports the hypothesis that CP binding is one critical function, held in common by
CARMIL1 and CARMIL2, that is targeted to vimentin filaments by
CARMIL2.
On the other hand, the CARMIL2 CP-binding mutant was able
to rescue the wound-healing cell migration defect of CARMIL2depleted cells. These cells lack lamellipodia, so this result provides
additional evidence that lamellipodia are dispensable for cell migration in certain contexts (Gupton et al., 2005; Suraneni et al.,
2012; Wu et al., 2012). A similar result was obtained for CARMIL1
(Edwards et al., 2013); therefore another function of CARMIL1 and
CARMIL2 must be necessary for cell migration in wound healing.
That function may be binding to membranes, which is mediated
by a basic and hydrophobic membrane-binding domain, as described by us in a separate study (Lanier et al., 2015).
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anti-GFP 6C5 and mouse mAb anti-GAPDH (Abcam, Cambridge,
MA); and Alexa Fluor–conjugated secondary antibodies (Life Technologies, Carlsbad, CA). To stain for F-actin, we used Alexa Fluor–
conjugated phalloidin (Sigma-Aldrich).

Cell culture, transfection, knockdown, and rescue
of CARMIL2

FIGURE 7: Model of CARMIL2 function in cells. CARMIL2 interacts
with dynamic vimentin filaments at the leading edge of cells through
its LRR domain. Interaction with vimentin is necessary for targeting
CARMIL2 and its domains, such as the CBR and basic and
hydrophobic membrane-binding domain, to functional membraneassociated locations for lamellipodia formation, cell migration, and
invadopodia formation.

The interaction of CARMIL2-CBR with CP decreased, but did not
eliminate, the ability of CP to bind barbed ends, as is the case for
CPI-motif proteins in general (Hernandez-Valladares et al., 2010;
Kim et al., 2012; Edwards et al., 2014). Thus CARMIL2 may have a
role in targeting CP to sites of actin assembly and in modulating its
capping activity, bringing it down to a level appropriate for a physiological setting (Yang et al., 2005; Uruno et al., 2006). Consistent
with this view, a recent study from our lab revealed that the interaction of CP with a CPI-motif protein is necessary for the function of CP
in cells (Edwards et al., 2015). In that study, expression of CP with
point mutations that ablate its interaction with the CPI motif caused
loss-of-function phenotypes in dominant-negative and expressionrescue experiments. One model for how CP may be activated by a
CPI motif is that CP may be constitutively inhibited by the protein
V1/myotrophin and that CPI-motif proteins relieve that inhibition by
an allosteric mechanism (Fujiwara et al., 2014).
On the basis of these results, we propose a model of CARMIL2
function in which vimentin filaments target CARMIL2 and its domains,
including the CBR, basic and hydrophobic membrane-binding domain, PH domain, and PRD, to critical membrane-associated sites for
lamellipodia formation, cell migration, and invadopodia-mediated
matrix degradation. (Figure 7). The properties of this novel multifunctional multidomain protein provide new insight into the molecular
mechanisms that underlie cancer cell invasion and migration.

MATERIALS AND METHODS
Antibodies and reagents
Reagents and materials were from Sigma-Aldrich (St. Louis, MO) or
Fisher Scientific (Pittsburgh, PA), unless stated otherwise. To detect
CARMIL2 protein, we produced a rabbit polyclonal antibody (pAb)
against a peptide consisting of amino acid residues 665–678 (HPTRARPRPRRQHH). To detect vimentin by immunostaining, we
used mouse monoclonal antibody (mAb) 3B4 (Millipore, Billerica,
MA). Other antibodies were as follows: mouse mAb anti-Flag M2
and horseradish peroxidase–conjugated secondary antibodies
(Sigma-Aldrich); mouse mAb anti-CP 2A3 (Developmental Studies
Hybridoma Bank, University of Iowa, Iowa City, IA); rabbit pAb
Volume 26 December 15, 2015

Plasmids are listed in Supplemental Table S1. Human CARMIL2b
cDNA (NCBI: FJ026014) and CARMIL1a (NCBI: FJ009082) were the
starting materials for all subcloning and chimera construction. GFP
fusions were created by subcloning CARMIL2 and fragments into
pAcGFP1-C1 (Clontech, Mountain View, CA) at BglII and HindIII
sites. CARMIL chimeras were created using Gibson assembly
methods (Gibson, 2011). For fragments and chimeras, truncation
and splice sites were chosen based on PSIPRED and alignments
with the mouse CARMIL1 structure of Zwolak et al. (2013). Adam
Zwolak and Roberto Dominguez of the University of Pennsylvania
provided critical advice on selecting sites to produce stable fragments. For chimeras, domain boundaries were as follows: PH1
1-147; PH2 1-148; LRR1 148-684; LRR2 149-687; C-Term1 6851371; C-Term2 688-1372. Vimentin (NCBI: NM_003380) was subcloned into tdTomato-N1 at the BglII and HindIII sites.
Human HT1080 cells (American Type Culture Collection,
Manassas, VA) were grown in DMEM (Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (SigmaAldrich) at 37°C with 5% CO2. Cells were transfected using TransitLT1 (Mirus, Madison, WI).
For depletion of endogenous CARMIL2, an shRNA construct targeting CARMIL2, in the lentiviral vector pFLRu-FH-GFP, was used
as previously described (Liang et al., 2009). The shRNA targeting
sequence was GCAAAGATGGCGAGATCAAG, with CAGTCGCGTTTGCGACTGG as a nontargeting scrambled control. For expression rescue, shRNA-resistant CARMIL2 constructs were subcloned
into pBOB-GFP for lentiviral-based expression as described (Mooren
et al., 2014). Resistance to shRNA was created with three codon-silent nucleotide changes (lowercase): GCAAgGAcGGgGAGATCAAG, using QuikChange mutagenesis (Stratagene, La  Jolla, CA).
The CARMIL2 RR985/987AA CP-binding mutant was created using
QuikChange site-directed mutagenesis (Stratagene).

Immunofluorescence, live-cell imaging, and image analysis
For immunofluorescence, HT1080 cells grown on glass coverslips
coated with 30 μg/ml fibronectin (Sigma-Aldrich) were fixed 24 h
posttransfection. For staining with fluorescent phalloidin or antibodies, cells were generally fixed in 2.5% paraformaldehyde and 0.25%
glutaraldehyde in PIPES buffer (125 mM NaCl, 5 mM KCl, 1.25 mM
NaH2PO4, 0.4 mM KH2PO4, 1 mM MgCl2, 5.5 mM glucose, 0.5 mM
ethylene glycol tetraacetic acid, 20 mM 1,4-piperazinediethanesulfonic acid, pH 7.1) at 37°C for 10 min, then quenched with 1 mg/ml
NaBH4 in Dulbecco’s phosphate-buffered saline (pH 7.1). Cells were
permeabilized with 0.1% Triton X-100 at room temperature for
10 min. Different fixation protocols were used for vimentin (ice-cold
MeOH at −20°C for 10 min) and CP (GlyoFixx at 37°C for 10 min;
Thermo-Scientific, Kalamazoo, MI). Immunostaining was performed
with the primary and secondary antibodies listed above. Cells were
imaged using 60×/1.4 numerical aperture (NA) and 100×/1.4 NA
objectives on an Olympus IX70 inverted microscope (Olympus, Melville, NY). Wide-field images were collected with a CoolSnap HQ
camera (Photometrics, Woburn, MA), and spinning-disk confocal
images were collected with an Orca Flash 4.0 camera (Hamamatsu,
Bridgewater, NJ). Images were collected and initially processed with
Micromanager (Edelstein et al., 2010) and ImageJ.
CARMIL2 links vimentin and actin
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For live-cell fluorescence movies, cells were grown on glass-bottom culture dishes (MatTek, Ashland, MA) coated with 30 μg/ml fibronectin (Sigma-Aldrich). Cells were maintained at 37°C with 5.0%
CO2. Spinning-disk confocal or wide-field fluorescence images were
captured every 6 s for up to 10 min using a 100×/1.4 NA objective.
Cells were imaged 24 h posttransfection. Heat-map pseudocoloring
was performed in ImageJ using the Fire look-up table.
For phase-contrast movies, cells were handled in a similar manner. Images of migrating single cells (n = 30) were acquired every
60 s for 1 h using a 60×/1.4 NA phase-contrast objective on an
Olympus IX70 inverted microscope. Cells were imaged 72 h postinfection with lentivirus. To avoid observer bias in selecting cells for
movie analysis, we imaged the first 30 isolated cells encountered
when systemically surveying the disk in a grid pattern.
To quantitate polarity, we calculated circularity as (areacell × 4π)/
(perimetercell2) (Thurston et al., 1988). ImageJ was used to measure
the area and perimeter of single cells from initial frames of timelapse movies (n = 30). Macropinosomes were counted as phasebright vesicles in the initial frame of phase-contrast time-lapse
movies (n = 30) of single cells. For calculating mean-squared displacement, distance traveled, and persistence, displacements of
individual cell nuclei were tracked frame by frame. For quantitation
of colocalization, Manders overlap coefficients were calculated using ImageJ from images of cells coexpressing GFP-CARMIL2 constructs and vimentin-tdTomato. Kymographs along vimentin filaments were generated using ImageJ with a 5-pixel line width.

Coimmunoprecipitations and immunoblots
Immunoprecipitation with anti-FLAG M2 affinity beads (Sigma-Aldrich) was performed according to the manufacturer’s instructions.
The beads were washed, and precipitated protein was eluted with
3X-FLAG peptide. Supernatant was boiled with SDS-loading buffer
and analyzed by SDS–PAGE and immunoblotting.
Immunoblots were performed with the primary and secondary
antibodies listed above. Immunoblots were developed with SuperSignal West Pico Chemiluminescent substrate (Thermo-Scientific)
and exposed to autoradiography film.

Protein expression and purification
The CBR fragments of human CARMIL2b Pro-961–Arg-1072 (pBJ
1843) were amplified from cDNA by PCR and cloned into pGEX6P-3 (GE Healthcare, Piscataway, NJ). Complete DNA sequencing
of the insert and junctions verified the identity and integrity of the
plasmids. The mutant CARMIL2-CBR RR985/987AA was created using QuikChange site-directed mutagenesis (Stratagene). GST-fusion
proteins were expressed in BL21 (DE3) Escherichia coli and purified
with glutathione Fast-Flow Sepharose resin (GE Healthcare). Cultures were grown and induced with isopropyl-β-d-thiogalactoside at
23°C. After elution from the glutathione resin, GST-CBR was mixed
with PreScission protease (GE Healthcare). The mixture was dialyzed
into S-Sepharose buffer A (10 mM Tris, pH 8.0, 10 mM KCl, 0.1 mM
EDTA, 0.5 mM dithiothreitol [DTT], 1 mM NaN3) overnight, applied
to an S-Sepharose column, and eluted with a KCl gradient (10–700
mM). For storage, CBR was dialyzed into 10 mM Tris (pH 8.0), 40
mM KCl, 0.1 mM EDTA, 0.5 mM DTT, and 1 mM NaN3 and kept on
wet ice. The concentration of CBR was calculated from A280, based
on predicted extinction coefficients, and confirmed by SDS–PAGE
with Coomassie blue staining.

Actin polymerization assays
Actin was purified from rabbit skeletal muscle as previously
described (Wear et al., 2003). Pyrene–actin polymerization assays,
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including inhibition and uncapping of by CARMIL, were performed
as described (Wear et al., 2003; Kim et al., 2012). The actin concentration was 1.5 μM, with 7% pyrene label. For capping assays, 10 nM
CP was added to a mixture of pyrene-labeled actin and spectrin–actin seeds at time zero. To assay for reversal of capping, pyrene–actin
was polymerized from seeds in the presence of 10 nM CP. After
200 s, the CBR fragment of CARMIL was added, and polymerization
was followed for 300 s. Apparent binding-affinity constants between
CP and CBR were determined by fitting the data to polymerization
rate equations with Berkeley Madonna (www.berkeleymadonna.
com), based on the following mechanism:
k+



→ ANb
Reaction 1 A + Nb ←

kk +cap



→ CPNb
Reaction 2 ANb + CP ←

k -cap
k +CBR


→ CPCBR
Reaction 3 CP + CBR ←

k -CBR

In these reactions, A is actin monomer, Nb is free barbed end, CP
is capping protein, CPNb is capped barbed end, and CBR is CBRCARMIL. These equations assume that a capped barbed end,
CPNb, can neither add nor lose actin subunits and that the complex
of CP with CARMIL, CPCBR, cannot interact with a barbed end. For
the elongation rate constants in Reaction 1, k+ was 11.6 μM−1s−1 and
k- was 1.4 s−1 (Pollard, 1986). The rate constants for capping in Reaction 2 were determined by fitting the experimental data for seeded
actin polymerization with a series of concentrations of CP. The rate
constants for CP binding to CARMIL in Reaction 3 were determined
by fitting a set of experimental data produced by addition of CARMIL at various concentrations to 10 nM CP.

Cell migration in a wound-healing model
HT1080 cells were infected with lentivirus for endogenous CARMIL2
depletion and expression rescue of mutants and chimeras. Infected
cells were grown to a confluent monolayer on glass-bottom cell culture dishes (MatTek) coated with 30 μg/ml fibronectin (SigmaAldrich). At 72 h postinfection, a wound was scratched with a pipette
tip. Measurements were made every hour for 4 h using an ocular
micrometer.

Invadopodia matrix-degradation assay
Coverslips coated with fluorescent gelatin (Life Technologies) were
prepared as previously described (Artym et al., 2009). HT1080 cells
were infected with lentivirus for depletion of CARMIL2 and expression rescue as above. At 72 h postinfection, cells were plated onto
fluorescent gelatin–coated coverslips. Cells were allowed to degrade the matrix for 3 h before fixation, permeabilization, and phalloidin staining.
To quantitate matrix degradation, we created a binary image
from the fluorescent gelatin image by imposing a threshold at three
SDs below the mean pixel intensity. Total cell area and area of degradation were measured from phalloidin-stained images and binary
images, respectively, using ImageJ. To avoid counting stray pixels in
the area of degradation, we constrained the analysis to areas greater
than 10 pixels.

Statistical analysis
We performed Student’s t test on population values to determine
whether means differed by statistically significant amounts. Data
analysis and graphical representations were done using Prism 6
(GraphPad, La  Jolla, CA).
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